Damalie Nakanjako
ID:
|
Inflammation and immune aging among HIV-infected adults with at least 12 years of antiretroviral therapy in an African cohort.
REFNo: HS194ES
1. To describe innate system phenotype and function [Natural killer (NK) cells, monocytes and innate lymphoid cells (ILCs)], after long-term suppressive HAART for at least 12 years of HAART, within the Infectious Diseases Institute (IDI) HIV treatment cohort.
2. To determine levels of immune aging markers among HIV-infected adults with suppressive ART, relative to age-and gender-matched HIV negative counterparts, despite twelve years and more of suppressive ART.
3. To describe those biological pathways which remain deranged after at least 12 years of suppressive HAART, and identify markers/pathways that are known to increase the risk of non-AIDS complications of chronic HIV.
|
Uganda |
2018-05-15 |
2021-05-15 |
Medical and Health Sciences |
|
Non-degree Award |
|
Joy Gumikiriza- Onoria Louise
ID:
|
SELF - PERCEPTIONS OF AGING AND QUALITY OF LIFE AMONG THE ELDERLY IN UGANDA
REFNo: HS195ES
To 1) Examine the association between quality of life and perceptions of aging among older people in rural and urban Uganda, 2) Translate and culturally adapt the Brief Aging perceptions questionnaire (B-APQ), and 3) Translate and culturally adapt the Older People’s Quality of Life questionnaire (OPQOL) for use with Luganda speaking older people in Uganda.
|
Uganda |
2018-05-15 |
2021-05-15 |
Medical and Health Sciences |
|
Non-degree Award |
|
Caitlin Jenks Alexandra
ID:
|
EVALUATION OF ANEMIA PREVENTION EFFORTS AFFECTING YOUTH IN IGANGA, UGANDA; CASE OF MUSANA COMMUNITY DEVELOMENT ORGANIZATION
REFNo: HS198ES
General Objective
To evaluate the quality of the current anemia prevention efforts at MCDO, as well as the behavior and beliefs around anemia from healthcare workers and other staff, so the findings can be used to enhance the organization’s strengths, and implement recommended changes.
Specific Objectives
Objective 1
To evaluate, through staff interviews and a research survey tool, the MCDO staff’s current knowledge and beliefs on anemia and how much emphasis they deem should be placed on prevention efforts.
Objective 2
To find out, through staff interviews and observations, if there are any current prevention efforts surrounding anemia on MCDO’s campuses including nutrition education, supplementation, deworming policies, and malaria prevention strategies.
Objective 3
To observe and evaluate qualitative data on the student’s consumption of food on a weekly basis, living quarters, classrooms, dining areas, and footwear of the nursery and primary school students at MCDO.
|
USA |
2018-05-15 |
2021-05-15 |
Medical and Health Sciences |
|
Degree Award |
|
Pakoyo Kamba Fadhiru
ID:
|
Burden and drivers of controlled prescription drug abuse among selected populations in Uganda
REFNo: HS203ES
The goal of this project is to determine the magnitude and factors associated with controlled prescription drug abuse among selected high risk populations in Uganda. There are five specific objectives:
• To establish the prevalence of controlled prescription drug abuse among health care workers in Uganda.
• To establish the prevalence of controlled prescription drug abuse among patients with mental disorders in Uganda.
• To establish the drivers of controlled prescription drug abuse among health care workers and patients with mental disorders in Uganda.
• To establish the compliance of Uganda’s medicine supply chain to regulations on controlled prescription drugs.
• To establish the factors associated with compliance of Uganda’s medicine supply chain to regulations on controlled prescription drugs
|
Uganda |
2018-05-15 |
2021-05-15 |
Medical and Health Sciences |
|
Non-degree Award |
|
Sylvia Nabukenya
ID: UNCST-2019-R000906
|
ASSESSMENT OF THE INFORMED CONSENT PROCESS FOR STUDIES INVOLVING GENETIC RESEARCH AMONG PEOPLE LIVING WITH HIV AT THE INFECTIOUS DISEASES INSTITUTE (IDI)
REFNo: HS199ES
1. To assess the adequacy of informed consent documents used for pharmacogenetic research and the collection, storage and future use of human samples.
2. To determine the methods used by researchers to ensure research participants’ understanding during the informed consent process in pharmacogenetic research.
3. To assess the factors that influence participants’ understanding during the consent process in pharmacogenetic research
|
Uganda |
2018-05-04 |
2021-05-04 |
Medical and Health Sciences |
|
Degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|